Does Shared Care Save Money for ADHD Treatment?

For many adults paying privately for ADHD treatment, the question is straightforward: does shared care save money? It can reduce ongoing prescription costs substantially once medication is stable, but it is not automatic, guaranteed or necessarily the right route for everyone. The most useful decision is one made with clear expectations about clinical safety, GP involvement and the costs at each stage.

What shared care means in ADHD treatment

Shared care is an arrangement in which a specialist psychiatrist and a GP agree how responsibility for a patient’s ongoing treatment will be managed. In adult ADHD care, the psychiatrist usually completes the assessment, confirms the diagnosis where appropriate, starts medication and oversees titration. Titration is the period in which the medication dose is adjusted carefully to find an option that is effective and tolerable.

When treatment is stable, the specialist may ask the GP to consider prescribing the agreed medication under an NHS prescription. The psychiatrist continues to provide clinical guidance, reviews and recommendations, while the GP takes on routine prescribing and monitoring where they are willing and able to do so.

This is not a transfer of all responsibility. ADHD medicines require appropriate monitoring and a clear plan for what should happen if symptoms return, side effects develop, physical health measures change or treatment needs to be adjusted.

How shared care can reduce treatment costs

The largest potential saving usually relates to medication. Private prescriptions involve the medicine cost as well as a private prescription charge, and the monthly price can vary considerably depending on the drug, dose and pharmacy. An NHS prescription, by comparison, is usually charged at the standard NHS prescription rate in England, unless you qualify for an exemption or prepayment certificate.

For someone who expects to take ADHD medication over a longer period, this difference can be meaningful. Moving from private dispensing to NHS prescribing may make ongoing treatment more affordable and predictable.

Shared care may also reduce the number of private appointments needed solely for issuing repeat prescriptions. However, patients should be cautious about viewing it as a way to eliminate private costs altogether. Specialist follow-up remains clinically valuable, and it may be required as part of the arrangement. Some people need a medication review every few months, while others who are stable may need reviews less often. The right frequency depends on the medicine, response, co-existing health conditions and individual circumstances.

Costs shared care does not remove

Private ADHD treatment normally has costs before shared care is even considered. These can include a diagnostic assessment, reports or supporting letters, medication initiation, titration appointments, private prescriptions and follow-up reviews.

A thorough assessment should not be rushed simply to reach a cheaper prescription route. Good ADHD care considers current symptoms, childhood history, functional impact, physical health, mental health, substance use where relevant, sleep, risk and personal goals. Medication is one part of a wider biopsychosocial plan, not a stand-alone answer to every difficulty.

There may also be costs after a GP accepts shared care. A consultant psychiatrist may recommend periodic specialist reviews, particularly if treatment is complex or a change in medication is being considered. If the GP asks for an updated specialist opinion before continuing prescriptions, that review will usually be private when treatment began privately.

It is therefore more accurate to think of shared care as a possible reduction in long-term medication costs rather than a fully funded private treatment pathway.

Is a GP required to accept shared care?

No. A GP is not obliged to enter into a shared care agreement with a private psychiatrist, even where the assessment and treatment plan are clinically thorough. The decision rests with the individual GP practice and may be shaped by local prescribing policies, capacity, familiarity with the medication, clinical governance requirements and whether the requested information is complete.

This can feel disappointing, especially after the time and financial commitment involved in a private assessment. It is not necessarily a reflection on the validity of the diagnosis or the quality of care. GP practices must make decisions within their own professional responsibilities and local NHS arrangements.

For that reason, it is sensible to speak with your GP practice early in the process. Ask whether they consider shared care for adult ADHD diagnosed and treated by an independent consultant psychiatrist, what documentation they require, and whether there are any local conditions they apply. A practice may be unable to give a final answer before seeing a full specialist report, but an early conversation can prevent misunderstandings later.

What makes a shared care request more likely to be workable?

A clear, clinically detailed handover gives a GP the information needed to make an informed decision. This generally includes the diagnosis, relevant assessment findings, medication history, the stable dose, treatment response, side effects, physical health monitoring, any risks or cautions, and a plan for future review.

The specialist should also remain available to advise on changes in treatment. A GP should not be placed in the position of initiating unfamiliar specialist medication without adequate support, or expected to manage a complex treatment plan without a defined route back to the psychiatrist.

At IamPsychiatry, the focus is on consultant-led assessment, safe medication titration and a clear treatment plan that can support continuity of care. Shared care is considered only when it is clinically appropriate and once medication has been stabilised.

When private prescribing may still be the better option

Shared care is not always the most practical route, even when it might lower prescription costs. Some patients prefer to keep all prescribing and reviews with one specialist clinician, particularly during a demanding period at work, while studying, or when symptoms and medication effects are still changing.

Private prescribing may also offer greater continuity where a GP practice does not accept shared care, where a patient moves frequently, or where treatment requires more frequent specialist adjustments. It can be a reasonable choice if you value a direct, consistent line to the clinician who knows your diagnostic history and treatment response.

There are clinical reasons to keep treatment under specialist prescribing too. These may include significant anxiety, depression, bipolar disorder, substance misuse concerns, cardiovascular issues, complex medication combinations or uncertainty about the diagnosis. In these situations, a slower and more closely supervised plan may be safer than pursuing the quickest route to a lower-cost prescription.

Looking beyond the prescription price

The financial question matters, but the cheapest option is not always the best value. Delays, inadequate monitoring or poorly coordinated care can create further stress and expense. A treatment plan that improves concentration, emotional regulation, sleep, work performance or daily functioning may have benefits that are not captured by the cost of a monthly prescription.

It is also worth considering what you need from care beyond medication. Adults with ADHD may benefit from practical coaching, psychological therapy, workplace adjustments, sleep support, treatment for co-existing conditions and help involving family or partners where appropriate. A personalised plan should reflect your priorities, not simply the availability of a shared-care arrangement.

Questions to ask before you start treatment

Before booking an assessment or beginning medication, ask the provider how titration works, what appointments and prescription costs may apply, how often reviews are expected, and what information will be provided to your GP. Ask whether the clinician has experience preparing shared

care documentation and what happens if your GP declines the request.

You can also ask your GP whether they have a shared-care policy and whether they need a particular format of report. Getting answers early enables you to budget realistically and choose a pathway that feels manageable.

Shared care can make stable ADHD medication more affordable, but its real value lies in well-coordinated, safe care between you, your GP and your specialist. The aim is not simply to spend less. It is to create a treatment plan you can sustain with confidence as you recover and enjoy life.